|
1
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
|
|
4
|
Lim LP, Lau NC, Garrett-Engele P, et al:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang H, Zhang H, Zhu L, Wang J, Zhang C
and Li D: Pathway analysis of cancer-associated microRNA targets.
Int J Oncol. 41:2213–2226. 2012.PubMed/NCBI
|
|
6
|
Zhu D, Pan C, Li L, et al:
MicroRNA-17/20a/106a modulate macrophage inflammatory responses
through targeting signal-regulatory protein alpha. J Allergy Clin
Immunol. 132:426–436.e8. 2013. View Article : Google Scholar
|
|
7
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cuellar TL and McManus MT: MicroRNAs and
endocrine biology. J Endocrinol. 187:327–332. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Poy MN, Eliasson L, Krutzfeldt J, et al: A
pancreatic islet-specific microRNA regulates insulin secretion.
Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L, Hou D, Chen X, et al: Exogenous
plant MIR168a specifically targets mammalian LDLRAP1: evidence of
cross-kingdom regulation by microRNA. Cell Res. 22:107–126. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
13
|
Loscalzo J, Kohane I and Barabasi AL:
Human disease classification in the postgenomic era: a complex
systems approach to human pathobiology. Mol Syst Biol. 3:1242007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nie W, Tang L, Zhang H, et al: Structural
analysis of the EGFR TK domain and potential implications for EGFR
targeted therapy. Int J Oncol. 40:1763–1769. 2012.PubMed/NCBI
|
|
15
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bishop JA, Benjamin H, Cholakh H, Chajut
A, Clark DP and Westra WH: Accurate classification of non-small
cell lung carcinoma using a novel microRNA-based approach. Clin
Cancer Res. 16:610–619. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Patnaik SK, Kannisto E, Knudsen S and
Yendamuri S: Evaluation of microRNA expression profiles that may
predict recurrence of localized stage I non-small cell lung cancer
after surgical resection. Cancer Res. 70:36–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Raponi M, Dossey L, Jatkoe T, et al:
MicroRNA classifiers for predicting prognosis of squamous cell lung
cancer. Cancer Res. 69:5776–5783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin PY, Yu SL and Yang PC: MicroRNA in
lung cancer. Br J Cancer. 103:1144–1148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mi H, Muruganujan A and Thomas PD: PANTHER
in 2013: modeling the evolution of gene function, and other gene
attributes, in the context of phylogenetic trees. Nucleic Acids
Res. 41:D377–D386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang da W, Sherman BT, Tan Q, et al: The
DAVID Gene Functional Classification Tool: a novel biological
module-centric algorithm to functionally analyze large gene lists.
Genome Biol. 8:R1832007.PubMed/NCBI
|
|
23
|
Kanehisa M, Araki M, Goto S, et al: KEGG
for linking genomes to life and the environment. Nucleic Acids Res.
36:D480–D484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takamizawa J, Konishi H, Yanagisawa K, et
al: Reduced expression of the let-7 microRNAs in human lung cancers
in association with shortened postoperative survival. Cancer Res.
64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kumar MS, Erkeland SJ, Pester RE, et al:
Suppression of non-small cell lung tumor development by the let-7
microRNA family. Proc Natl Acad Sci USA. 105:3903–3908. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X
and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell
lung cancer A549 cells through targeting BCL-2. Int J Biol Sci.
7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong KK: Searching for a magic bullet in
NSCLC: the role of epidermal growth factor receptor mutations and
tyrosine kinase inhibitors. Lung Cancer. 60(Suppl 2): S10–S18.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Webster RJ, Giles KM, Price KJ, Zhang PM,
Mattick JS and Leedman PJ: Regulation of epidermal growth factor
receptor signaling in human cancer cells by microRNA-7. J Biol
Chem. 284:5731–5741. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chou YT, Lin HH, Lien YC, et al: EGFR
promotes lung tumorigenesis by activating miR-7 through a
Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor
ERF. Cancer Res. 70:8822–8831. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hayashita Y, Osada H, Tatematsu Y, et al:
A polycistronic microRNA cluster, miR-17–92, is overexpressed in
human lung cancers and enhances cell proliferation. Cancer Res.
65:9628–9632. 2005.
|
|
34
|
Mendell JT: miRiad roles for the miR-17–92
cluster in development and disease. Cell. 133:217–222.
2008.PubMed/NCBI
|
|
35
|
Seike M, Goto A, Okano T, et al: MiR-21 is
an EGFR-regulated anti-apoptotic factor in lung cancer in
never-smokers. Proc Natl Acad Sci USA. 106:12085–12090. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu W, Liu X, He J, Chen D, Hunag Y and
Zhang YK: Overexpression of members of the microRNA-183 family is a
risk factor for lung cancer: a case control study. BMC Cancer.
11:3932011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu S, Lu Z, Liu C, et al: miRNA-96
suppresses KRAS and functions as a tumor suppressor gene in
pancreatic cancer. Cancer Res. 70:6015–6025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang G, Mao W, Zheng S and Ye J: Epidermal
growth factor receptor-regulated miR-125a-5p - a metastatic
inhibitor of lung cancer. FEBS J. 276:5571–5578. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang L, Huang Q, Chang J, Wang E and Qiu
X: MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in
lung cancer cells. Exp Lung Res. 37:387–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Weiss GJ, Bemis LT, Nakajima E, et al:
EGFR regulation by microRNA in lung cancer: correlation with
clinical response and survival to gefitinib and EGFR expression in
cell lines. Ann Oncol. 19:1053–1059. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cho WCS, Chow ASC and Au JSK: Restoration
of tumour suppressor hsa-miR-145 inhibits cancer cell growth in
lung adenocarcinoma patients with epidermal growth factor receptor
mutation. Eur J Cancer. 45:2197–2206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen Z, Zeng H, Guo Y, et al: miRNA-145
inhibits non-small cell lung cancer cell proliferation by targeting
c-Myc. J Exp Clin Cancer Res. 29:1512010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yin R, Zhang S, Wu Y, et al: microRNA-145
suppresses lung adenocarcinoma-initiating cell proliferation by
targeting OCT4. Oncol Rep. 25:1747–1754. 2011.PubMed/NCBI
|
|
44
|
Cho WCS, Chow ASC and Au JSK: MiR-145
inhibits cell proliferation of human lung adenocarcinoma by
targeting EGFR and NUDT1. RNA Biol. 8:125–131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sachdeva M and Mo YY: MicroRNA-145
suppresses cell invasion and metastasis by directly targeting mucin
1. Cancer Res. 70:378–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang H, Zhang H, Zhu L, Zhang C and Li D:
Identification and characterization of microRNAs in macaca
fascicularis by EST analysis. Comp Funct Genomics.
2012:9576072012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
van Nimwegen E: Scaling laws in the
functional content of genomes. Trends Genet. 19:479–484.
2003.PubMed/NCBI
|
|
48
|
Kim JS, Lee Y, Lee MY, et al: Multiple
reaction monitoring of multiple low-abundance transcription factors
in whole lung cancer cell lysates. J Proteome Res. 12:2582–2596.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Engelman JA, Zejnullahu K, Mitsudomi T, et
al: MET amplification leads to gefitinib resistance in lung cancer
by activating ERBB3 signaling. Science. 316:1039–1043. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Carpenter CL and Cantley LC:
Phosphoinositide kinases. Curr Opin Cell Biol. 8:153–158. 1996.
View Article : Google Scholar
|
|
51
|
Hennessy BT, Smith DL, Ram PT, Lu Y and
Mills GB: Exploiting the PI3K/AKT pathway for cancer drug
discovery. Nat Rev Drug Discov. 4:988–1004. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cuevas BD, Winter-Vann AM, Johnson NL and
Johnson GL: MEKK1 controls matrix degradation and tumor cell
dissemination during metastasis of polyoma middle-T driven mammary
cancer. Oncogene. 25:4998–5010. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hynes NE and MacDonald G: ErbB receptors
and signaling pathways in cancer. Curr Opin Cell Biol. 21:177–184.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sebolt-Leopold JS and Herrera R: Targeting
the mitogen-activated protein kinase cascade to treat cancer. Nat
Rev Cancer. 4:937–947. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gatza ML, Watt JC and Marriott SJ:
Cellular transformation by the HTLV-I Tax protein, a
jack-of-all-trades. Oncogene. 22:5141–5149. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
van Nimwegen MJ, Verkoeijen S, van Buren
L, Burg D and van de Water B: Requirement for focal adhesion kinase
in the early phase of mammary adenocarcinoma lung metastasis
formation. Cancer Res. 65:4698–4706. 2005.PubMed/NCBI
|
|
58
|
Yamaguchi H and Condeelis J: Regulation of
the actin cytoskeleton in cancer cell migration and invasion.
Biochim Biophys Acta. 1773:642–652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Semba S, Iwaya K, Matsubayashi J, et al:
Coexpression of actin-related protein 2 and Wiskott-Aldrich
syndrome family verproline-homologous protein 2 in adenocarcinoma
of the lung. Clin Cancer Res. 12:2449–2454. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Dasgupta P, Kinkade R, Joshi B, Decook C,
Haura E and Chellappan S: Nicotine inhibits apoptosis induced by
chemotherapeutic drugs by up-regulating XIAP and survivin. Proc
Natl Acad Sci USA. 103:6332–6337. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang S, Togo S, Minakata K, Gu T, Ohashi
R, Tajima K, Murakami A, Iwakami S, Zhang J, Xie C and Takahashi K:
Distinct roles of cholinergic receptors in small cell lung cancer
cells. Anticancer Res. 30:97–106. 2010.PubMed/NCBI
|
|
62
|
Burger AM and Seth AK: The
ubiquitin-mediated protein degradation pathway in cancer:
therapeutic implications. Eur J Cancer. 40:2217–2229. 2004.
View Article : Google Scholar : PubMed/NCBI
|
